The Therapeutic Potential of Adipose Tissue-Derived Mesenchymal Stem Cells to Enhance Radiotherapy Effects on Hepatocellular Carcinoma

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2019 Nov 30

PMID 31781559

Citations 18

Authors

Lingyun Wu

Qiuying Tang

Xin Yin

Danfang Yan

Mengmeng Tang

Jiaojiao Xin

Qiaoling Pan

Chiyuan Ma

Senxiang Yan

Affiliations

Soon will be listed here.

Abstract

Several studies have investigated strategies to improve the clinical efficacy of radiotherapy (RT) against hepatocellular carcinoma (HCC), yet the prognosis remains poor. Human adipose tissue-derived mesenchymal stem cells (AT-MSCs), easily accessible and abundant in quantity, have represented as an attractive therapeutic tool for the stem cell-based treatment for cancer diseases. Through direct co-culture and indirect separate culture experiments, we showed that AT-MSCs could enhance inhibitory effect of RT on reducing HCC cell growth, migration and invasion in both and experiments. RNA-sequencing analysis revealed a noticeable interferon-induced transmembrane 1 (IFITM1)-induced tumor gene signature. Gain and loss of mechanistic studies indicated that mechanism was attributed to downregulated expression of signal transducer and activator of transcription 3 (STAT3) and matrix metallopeptidases (MMPs) and upregulated expression of P53 and caspases. Collectively, our findings suggest that AT-MSCs might enhance the therapeutic effects of RT on HCC, providing a rationale for AT-MSCs and RT combination therapy as a new remedy for HCC.

Citing Articles

Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma.

Gladys A, Mazurski A, Czekaj P Int J Mol Sci. 2024; 25(14).

PMID: 39063048 PMC: 11277008. DOI: 10.3390/ijms25147806.

Mesenchymal-Stem-Cell-Based Therapy against Gliomas.

Santillan-Guajan S, Shahi M, Castresana J Cells. 2024; 13(7.

PMID: 38607056 PMC: 11011546. DOI: 10.3390/cells13070617.

Transcriptome wide functional analysis of HBx expressing human hepatocytes stimulated with endothelial cell cross-talk.

Ghufran S, Sharma P, Roy B, Jaiswal S, Aftab M, Sengupta S Genomics. 2023; 115(4):110642.

PMID: 37209778 PMC: 7615065. DOI: 10.1016/j.ygeno.2023.110642.

Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies.

Charles J, Vrionis A, Mansur A, Mathias T, Shaikh J, Ciner A Cancers (Basel). 2023; 15(9).

PMID: 37174089 PMC: 10177356. DOI: 10.3390/cancers15092624.

Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma.

Qiao S, Zhang W, Su Y, Jiang Y Front Oncol. 2023; 12:1037535.

PMID: 36591519 PMC: 9795034. DOI: 10.3389/fonc.2022.1037535.

References

Lui A, Geanes E, Ogony J, Behbod F, Marquess J, Valdez K . IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Lett. 2017; 399:29-43. PMC: 5530765. DOI: 10.1016/j.canlet.2017.04.005. View

Friedman D, Baird J, Young K, Cottam B, Crittenden M, Friedman S . Programmed cell death-1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma. Hepatol Res. 2016; 47(7):702-714. DOI: 10.1111/hepr.12789. View

Sasportas L, Kasmieh R, Wakimoto H, Hingtgen S, van de Water J, Mohapatra G . Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A. 2009; 106(12):4822-7. PMC: 2660771. DOI: 10.1073/pnas.0806647106. View

Gao F, Liang H, Lu H, Wang J, Xia M, Yuan Z . Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approach. Clin Epigenetics. 2015; 7:86. PMC: 4546208. DOI: 10.1186/s13148-015-0121-1. View

Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao R . Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005; 332(2):370-9. DOI: 10.1016/j.bbrc.2005.04.135. View

Yang Y, Koh Y, Sari I, Jun N, Lee S, Thi Hanh Phi L . Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer. Int J Cancer. 2018; 144(8):2020-2032. PMC: 6587945. DOI: 10.1002/ijc.31926. View

Brade A, Ng S, Brierley J, Kim J, Dinniwell R, Ringash J . Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2016; 94(3):580-7. DOI: 10.1016/j.ijrobp.2015.11.048. View

Klopp A, Gupta A, Spaeth E, Andreeff M, Marini 3rd F . Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells. 2011; 29(1):11-9. PMC: 3059412. DOI: 10.1002/stem.559. View

Li T, Song B, Du X, Wei Z, Huo T . Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study. Eur J Med Res. 2013; 18:34. PMC: 3850116. DOI: 10.1186/2047-783X-18-34. View

10.

Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A . Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 2006; 66(4):1949-55. DOI: 10.1158/0008-5472.CAN-05-2731. View

11.

Lee S, Kim W, Lim C, Chung S . Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study. Stem Cells. 2015; 33(10):2995-3005. DOI: 10.1002/stem.2110. View

12.

Keane F, Hong T, Zhu A . Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy. Semin Radiat Oncol. 2018; 28(4):332-341. DOI: 10.1016/j.semradonc.2018.06.006. View

13.

Yang J, Li L, Xi Y, Sun R, Wang H, Ren Y . Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer. Cancer Sci. 2018; 109(10):3115-3128. PMC: 6172064. DOI: 10.1111/cas.13640. View

14.

Bacakova L, Zarubova J, Travnickova M, Musilkova J, Pajorova J, Slepicka P . Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review. Biotechnol Adv. 2018; 36(4):1111-1126. DOI: 10.1016/j.biotechadv.2018.03.011. View

15.

Ciavarella S, Grisendi G, Dominici M, Tucci M, Brunetti O, Dammacco F . In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. Br J Haematol. 2012; 157(5):586-98. DOI: 10.1111/j.1365-2141.2012.09082.x. View

16.

Fu Y, Zhou Z, Wang H, Gong P, Guo R, Wang J . IFITM1 suppresses expression of human endogenous retroviruses in human embryonic stem cells. FEBS Open Bio. 2017; 7(8):1102-1110. PMC: 5537067. DOI: 10.1002/2211-5463.12246. View

17.

Ma S, Jiao B, Liu X, Yi H, Kong D, Gao L . Approach to radiation therapy in hepatocellular carcinoma. Cancer Treat Rev. 2009; 36(2):157-63. DOI: 10.1016/j.ctrv.2009.11.008. View

18.

Ho I, Toh H, Ng W, Teo Y, Guo C, Hui K . Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells. 2012; 31(1):146-55. DOI: 10.1002/stem.1247. View

19.

Jung P, Ryu H, Rhee K, Hwang S, Lee C, Gwon S . Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and TRAIL and suppress the growth of H460 human lung cancer cells. Cancer Lett. 2018; 440-441:202-210. DOI: 10.1016/j.canlet.2018.10.017. View

20.

Yan J, Jiang Y, Lu J, Wu J, Zhang M . Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1). Biomed Res Int. 2019; 2019:9085435. PMC: 6530206. DOI: 10.1155/2019/9085435. View